A startup founded on the premise that nearly half of all deaths in Latin America are preventable just landed one of the biggest venture checks in the region’s healthtech space. Telepatia AI has closed a $33 million Series A round led by Andreessen Horowitz, bringing its total funding to $42 million.

The company builds what it calls an “AI Doctor” platform, a clinical copilot and scribe tool designed to help physicians in Latin American hospitals make better decisions, faster. In a region where 43% of deaths are considered avoidable, the pitch practically writes itself.

What Telepatia actually does

The platform provides real-time transcription of medical visits, automatically generates structured electronic health records, and delivers evidence-based decision support to physicians as they work. It plugs into existing hospital systems rather than requiring institutions to rip out their current infrastructure.

The company claims its tools save physicians more than two hours of administrative work daily. Telepatia also reports that protocol adherence improves by more than 15% when clinicians use the platform.

The startup has already processed over 5 million consultations and counts more than 20 healthcare institutions among its clients. Some services are offered for free to private-practice physicians.

The money and the people behind it

Before this Series A, Telepatia had raised $9 million in a seed round in October 2025. That earlier round was led by A-Star with participation from Canary, Abstract Ventures, and Picus Capital. SV Angel also joined the cap table.

Palantir’s Shyam Sankar and Nubank’s David Vélez both sit on Telepatia’s board. Founder Nicolás Abad, who is affiliated with Stanford, has spoken publicly about how his father’s death motivated him to tackle healthcare gaps in the region. The company was built by a team of doctors and engineers.

Why Latin American healthtech matters right now

Latin America has seen a wave of healthtech investment in recent years, but most of it has focused on telemedicine and pharmacy delivery. Rather than replacing the doctor-patient interaction, Telepatia’s platform augments it by surfacing relevant evidence, flagging potential issues, and handling administrative burden. The AI provides decision support rather than making diagnoses, keeping the physician in the loop and retaining clinical responsibility.

The free tier for private-practice physicians targets independent practitioners who lack the institutional support and technology access that hospital-based doctors enjoy.